ArticleTherapeutic advances in drug safety2025
Development and validation of a risk-prediction model for adverse drug reactions in real-world cancer patients treated with anlotinib.
Jiajia Qian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.